RapidAI, whose platform leverages deep learning intelligence to help diagnose vascular and neurovascular conditions, raised a $75 million Series C, CEO Karim Karti tells Axios exclusively.
Why it matters: With strokes the second leading cause of death worldwide — and as hospitals remain understaffed — demand for tools that help with triage keeps growing.
